A SNaPshot assay for the rapid and simple detection of four common hotspot codon mutations in the PIK3CA gene

Carolyn D Hurst1, Tahlita C M Zuiverloon, Christian Hafner

  • 1Cancer Research UK Clinical Centre, Leeds Institute of Molecular Medicine, St James's University Hospital, Leeds, UK. c.hurst@leeds.ac.uk

BMC Research Notes
|May 1, 2009
PubMed
Abstract

Insights

A new SNaPshot assay enables rapid, sensitive, and cost-effective detection of common PIK3CA gene mutations in cancer. This method accurately identifies mutations in various sample types, improving diagnostic capabilities.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Activating mutations in the PIK3CA gene are prevalent in human cancers, often found in exons 9 and 20.
  • Current methods for detecting PIK3CA mutations are often costly and time-consuming.

Purpose of the Study:

  • To develop and evaluate a novel SNaPshot assay for the rapid screening of frequent PIK3CA hotspot mutations.
  • To provide a more efficient diagnostic tool for PIK3CA-driven malignancies.

Main Methods:

  • Development of a SNaPshot assay combining multiplex PCR and primer extension for simultaneous detection of four common PIK3CA mutations (E542K, E545G, E545K, H1047R).
  • Validation using samples previously analyzed by high-resolution melting analysis and sequencing.
  • Assessment of sensitivity and application to formalin-fixed paraffin-embedded (FFPE) samples.

Main Results:

  • The SNaPshot assay successfully detected four frequent PIK3CA hotspot mutations with high concordance and no false positives.
  • The assay demonstrated sensitivity in detecting mutant DNA at 5-10% levels.
  • The method was successfully applied to DNA from FFPE samples.

Conclusions:

  • The developed SNaPshot assay is a fast, sensitive, inexpensive, and specific method for analyzing common PIK3CA mutations.
  • This assay is suitable for both fresh and archival patient samples, offering a valuable diagnostic tool.

Related Concept Videos